跳至主要内容
临床试验/NCT02325388
NCT02325388已完成不适用

Effectiveness of a Pressure-sensing System to Reduce the Risk of Pressure Ulcer Formation by Lowering Interface Pressure in Vulnerable Patient Populations: A Parallel-two-group Randomized Controlled Trial

University of Calgary1 个研究点 分布在 1 个国家目标入组 678 人开始时间: 2014年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
678
试验地点
1
主要终点
Interface pressure analysis - sensel pressure reading

研究概览

简要总结

Pressure ulcers are prevalent conditions that result in substantial financial costs to the healthcare system as well as significant distress to affected patients and their families. This study is a parallel two-group randomized controlled trial that aims to study how the use of a pressure sensing device with continuous visual feedback of pressure imaging may potentially decrease the interface pressure of patients who are at risk of pressure ulcers in an acute hospital setting.

详细描述

Background: Pressure ulcers result in substantial financial costs to the healthcare system as well as significant distress to affected patients and their families. As interface pressure is a key risk factor in the development of pressure ulcers, continuous visual feedback of continuous pressure imaging (CPI) between the body and support surface could inform healthcare providers on repositioning strategies and play a key role in an overall strategy for the prevention and management of pressure ulcers. This randomized, controlled trial aims to study the effect of CPI on the reduction of interface pressure, and the incidence of pressure ulcers in vulnerable hospital patients.

Methods: A parallel two-group randomized controlled clinical trial will be conducted. A total of 678 eligible consenting inpatients at high risk of pressure ulcer development in a tertiary acute care institution will be randomly allocated to either have the ForeSite PT™ system with the liquid-crystal display ("LCD") monitor turned on to provide visual feedback through CPI to healthcare providers while also collecting continuous interface pressure data (intervention group), or have the ForeSite PT™ system with the LCD monitor turned off, therefore not providing visual feedback or CPI to healthcare providers, while collecting continuous interface pressure data in the background (control group), in a ratio of 1:1. Data will be collected on both groups for three days (72 hours). The primary outcome will be the differences in the two groups' interface pressure analysis. The interface pressure readings will be collected through hourly sampling of continuous interface pressure recordings taken throughout this study period. Clinical outcomes will be the differences in the two groups' pressure-related skin and soft tissue change in areas at risk of pressure ulcer. It will be obtained at baseline (within 24 hours of admission) and on the third day of the trial. Perceptions of intervention patients and healthcare providers will be obtained on the third day.

Discussion: This will be the first randomized controlled trial to investigate the effect of CPI on interface pressure of vulnerable hospital patients, and the association between interface pressure and development of pressure-related skin and soft tissue changes. The results could provide important information to guide clinical practice in the prevention and management of pressure ulcers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult, man or woman, with a minimum age limit of 18 years old.
  • •Expected to have a length of stay on the unit of at least three days.
  • •Require assistance with bed mobility or completely dependent for bed mobility as determined by the "Bed" components in the de Morton Mobility Index (DEMMI). Eligible patients would be:
  • •Unable (score of "0") to bridge, roll onto their side, and sit from lying supine.
  • •Unable (score of "0") to bridge and roll onto their side, and requires minimal assistance and/or supervision with sitting from lying supine.
  • •Able (score of "1") to bridge, unable to roll onto their side (score of "0"), and requires minimal assistance and/or supervision with sitting from lying supine.
  • •Capacity to provide consent, or have a surrogate decision-maker provide consent on their behalf.
  • •Not near the end of life within three days of enrolment in the study.

排除标准

  • •Have a planned admission to another unit (including those identified as a setting for data collection in the study) within three days of enrolment in the study.
  • •Sleep in a chair at night.
  • •Whose clinical care would be negatively impacted if turned or repositioned.

研究组 & 干预措施

Treatment group with ForeSite PT™ system

Experimental

Inpatients assigned to the treatment group with the ForeSite PT™ system will have its LCD monitor turned on (i.e., real-time images of interface pressure will be displayed on the monitor) during their enrolment in the trial.

干预措施: ForeSite PT™ system (Device)

Control group

No Intervention

Inpatients assigned to the control group will have the ForeSite PT™ system's LCD monitor turned off and hidden (i.e., real-time images of interface pressure will not be displayed on the monitor). As the ForeSite PT™ system will continue to record interface pressure with the display turned off, this enables patients enrolled in the control group to undergo silent monitoring.

结局指标

主要结局

Interface pressure analysis - sensel pressure reading

时间窗: 72 hours

Absolute number of sensels with pressure readings greater than 40 mmHg

Interface pressure analysis - % with pressure over 40mmHg

时间窗: 72 hours

Proportion of participants that have pressure readings greater than 40 mmHg

Interface pressure analysis - peak pressure

时间窗: 72 hours

Peak pressure of any given pressure reading sample

Interface pressure analysis - average pressure

时间窗: 72 hours

Average interface pressure (excluding sensels with 0mmHg reading)

次要结局

  • Pressure related skin and soft tissue changes(72 hours)
  • Perceptions of patients(72 hours)
  • Perceptions of healthcare providers(72 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chester Ho, MD

Associate Professor

University of Calgary

研究点 (1)

Loading locations...

相似试验